Sale!

EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EEF2 gene spinocerebellar ataxia type 26 (SCA26) autosomal dominant genetic test is a specialized diagnostic tool used to detect mutations in the EEF2 gene, which have been linked to SCA26. Spinocerebellar ataxia type 26 is a rare, inherited neurological disorder characterized by progressive coordination problems, difficulty walking, and other motor system impairments due to cerebellar atrophy. Since SCA26 follows an autosomal dominant inheritance pattern, having just one copy of the altered gene is sufficient to cause the disorder.

This genetic test is crucial for individuals with a family history of SCA26 or those showing symptoms suggestive of the condition. Early and accurate diagnosis through this test can aid in the management of symptoms, genetic counseling, and planning for the future.

The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, comprehensive support, and guidance on the implications of the findings for their health and lifestyle.

Description

EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test

Are you concerned about Spinocerebellar Ataxia Type 26 (SCA26)? DNA Labs UAE offers the EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test to provide a comprehensive assessment of genetic variations associated with this neurological disorder.

Test Details

The EEF2 gene is associated with Spinocerebellar Ataxia Type 26 (SCA26), an autosomal dominant form of ataxia. Ataxia is a neurological disorder characterized by a lack of muscle control or coordination, leading to problems with balance, speech, and movement.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive assessment of genetic variations. In the context of SCA26, NGS genetic testing can be used to identify mutations or variations in the EEF2 gene that may be responsible for the development of the disorder.

By analyzing the EEF2 gene using NGS, healthcare professionals can determine if there are any disease-causing mutations present. This information can help in confirming a diagnosis of SCA26, providing prognostic information, and guiding treatment decisions.

It is important to note that genetic testing for SCA26 is typically performed in individuals with symptoms consistent with ataxia or a family history of the condition. Genetic counseling is often recommended before and after testing to discuss the potential implications of the results.

Test Components and Price

The EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test is priced at 4400.0 AED.

Sample Condition

The test can be performed on blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-Generation Sequencing) technology.

Test Type

The EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test falls under the category of neurological disorders.

Doctor and Test Department

The test is conducted by a neurologist and falls under the Genetics department.

Pre-Test Information

Prior to the EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session may also be conducted to draw a pedigree chart of family members affected by SCA26.

Take control of your health and get the answers you need. Contact DNA Labs UAE today to schedule your EEF2 Gene Spinocerebellar Ataxia Type 26 Autosomal Dominant Genetic Test.

Test Name	EEF2 Gene Spinocerebellar ataxia type 26 autosomal dominant Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for EEF2 Gene Spinocerebellar ataxia type 26, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EEF2 Gene Spinocerebellar ataxia type 26, autosomal dominant
Test Details	The EEF2 gene is associated with Spinocerebellar ataxia type 26 (SCA26), an autosomal dominant form of ataxia. Ataxia is a neurological disorder characterized by a lack of muscle control or coordination, leading to problems with balance, speech, and movement. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive assessment of genetic variations. In the context of SCA26, NGS genetic testing can be used to identify mutations or variations in the EEF2 gene that may be responsible for the development of the disorder. By analyzing the EEF2 gene using NGS, healthcare professionals can determine if there are any disease-causing mutations present. This information can help in confirming a diagnosis of SCA26, providing prognostic information, and guiding treatment decisions. It is important to note that genetic testing for SCA26 is typically performed in individuals with symptoms consistent with ataxia or a family history of the condition. Genetic counseling is often recommended before and after testing to discuss the potential implications of the results.

Browse

Want to chat?

Social